MedTrace Logo

COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases

NCT04335747 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2021-07-21

No results posted yet for this study

Summary

The trial is a prospective, observational study aiming to identify risk factors for serious COVID-19 infection by evaluating clinical measures and biomarkers of inflammation in patients with inflammatory rheumatic disease hospitalized with COVID-19 compared with control groups.

Conditions

Interventions

OTHER

COVID-19 infection

Hospitalisation due to a confirmed COVID-19 infection

Sponsors & Collaborators

  • Salome Kristensen

    lead OTHER

Principal Investigators

  • Salome Kristensen, MD, PhD · Department of Rheumatology, Aalborg University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-23
Primary Completion
2021-07-01
Completion
2021-07-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04335747 on ClinicalTrials.gov